1. Demonstrate an understanding of the pathophysiology of skin and soft tissue infections (SSTIs) and the complications associated with SSTIs in pediatric patients.
2. Assess the bacterial etiologies and risk factors associated with SSTIs in pediatric patients.
3. Assess common pediatric bacterial SSTIs based on clinical presentation.
4. Evaluate diagnostic strategies for SSTIs in children, including indications for obtaining cultures and imaging.
5. Develop evidence-based pharmacologic and nonpharmacologic treatment plans, emphasizing empiric antibiotic selection, dosing, route of administration, and duration for various bacterial SSTIs.
6. Design pediatric patient􀂱specific treatment plans based on patient-specific factors that influence antibiotic regimen selection (eg, age, antibiotic allergy history, pathogen identified) for SSTIs.
7. Evaluate the recent updates and expanded indications used in pediatric SSTIs.

1. Apply the principles of rational polypharmacy including, but not limited to, its associated challenges when developing treatment regimens for pediatric patients with epilepsy.
2. Evaluate the role of novel therapeutic and abortive antiseizure medications (ASMs) in the treatment regimens of pediatric patients with epilepsy.
3. Distinguish between the basic principles of precision medicine (PM) and emerging molecular and gene therapies for pediatric patients with epilepsy.

1. Distinguish incidence and common etiology of hypertension (HTN) in the pediatric population.
2. Analyze and apply appropriate lifestyle and nonpharmacologic interventions for pediatric HTN.
3. Analyze and apply appropriate pharmacologic treatment options for pediatric HTN unresponsive to lifestyle modifications and nonpharmacologic interventions.
4. Demonstrate appropriate antihypertensive treatment optimization and associated blood pressure management follow-up.
5. Analyze and apply appropriate pharmacologic treatment options for children with acute severe HTN.
6. Evaluate appropriate pharmacologic antihypertensive therapies in special pediatric populations.

1. Demonstrate an understanding of the prevalence and classification of anemia in the pediatric patient.
2. Distinguish when to initiate health screenings for anemia in pediatric patients based on risk factors.
3. Develop a strategy for the prevention of anemia in the community.
4. Analyze and design a therapeutic plan for patients with anemia and anemia related to chronic conditions.
5. Evaluate therapeutic options for patients with acute anemia.

1. Evaluate controversies in growth hormone stimulation testing.
2. Design an appropriate treatment regimen and monitoring plan for a pediatric patient with growth hormone deficiency.
3. Distinguish the role and place in therapy of long-acting growth hormone therapy.
4. Analyze available data on long-term safety risks of growth hormone usage.
5. Devise an appropriate treatment regimen and monitoring plan for a patient transitioning from pediatric to adult care.

1. Distinguish differences between early and older-onset inflammatory bowel disease (IBD).
2. Evaluate evidence surrounding conventional therapies for children with IBD.
3. Analyze available data on biologics and small-molecule inhibitors for pediatric IBD.
4. Design a monitoring and treatment plan for a child with IBD based on patient-specific factors and risk-benefit assessment.
5. Devise supportive care medication strategies to mitigate IBD-sequelae and treatment-related adverse effects.

1. Develop an appropriate care plan for a patient with a life-limiting condition.
2. Evaluate care plan to align with patient-specific goals of care.
3. Design an appropriate symptom management plan for a pediatric palliative care patient.
4. Assess medication appropriateness as patients approach end of life.

1. Analyze available cystic fibrosis transmembrane regulator (CFTR) modulator therapies, including associated benefits, adverse effects, and impacts on overall disease management.
2. Evaluate the impacts of CFTR modulator therapies on other aspects of disease management.
3. Design an appropriate therapeutic plan for treatment of a pediatric patient with a CF exacerbation.

1. Apply strategies for mitigating potential medication safety issues when treating pregnancy emergencies.
2. Evaluate the appropriateness of a medication regimen for an obstetric emergency on the basis of current evidence and recommendations.
3. Design an effective therapeutic plan for a pregnant or postpartum patient with an obstetric emergency.
4. Assess the risk of neonatal effects from pharmacotherapy used during pregnancy emergencies.